News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ajinomoto Aminoscience LLC Creates Viable Protein Expression Opportunities for Global Pharmaceutical Company


5/3/2011 10:35:52 AM

RALEIGH, N.C.--(BUSINESS WIRE)--Ajinomoto AminoScience LLC (AAS) today announced the availability of a case study profiling how one global pharmaceutical company relied on the CorynexTM Recombinant Protein Expression System to simplify the development of recombinant proteins.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES